BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31135956)

  • 1. Dermoscopic characterization of folliculotropic mycosis fungoides selectively localized on trunk and limbs.
    Caccavale S; Vitiello P; Franco R; Panarese I; Ronchi A; Sica A; Jurakic Toncic R; Alfano R; Argenziano G
    Int J Dermatol; 2019 Oct; 58(10):e187-e189. PubMed ID: 31135956
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermoscopic characterization of cutaneous lymphomas: a pilot survey.
    Ghahramani GK; Goetz KE; Liu V
    Int J Dermatol; 2018 Mar; 57(3):339-343. PubMed ID: 29318585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation.
    Chan WH; Lewis DJ; Hinojosa T; Curry JL; Duvic M
    Pediatr Dermatol; 2018 Jan; 35(1):e13-e16. PubMed ID: 29159918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases.
    Muniesa C; Estrach T; Pujol RM; Gallardo F; Garcia-Muret P; Climent J; Servitje O
    J Am Acad Dermatol; 2010 Mar; 62(3):418-26. PubMed ID: 20079954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A.
    Amitay-Laish I; Prag-Naveh H; Dalal A; Pavlovsky L; Feinmesser M; Hodak E
    Acta Derm Venereol; 2018 Nov; 98(10):951-955. PubMed ID: 30085321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA.
    Krönke A; Schlaak M; Arin M; Mauch C; Kurschat P
    Eur J Dermatol; 2012; 22(2):259-60. PubMed ID: 22240623
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulomatous mycosis fungoides.
    Telle H; Koeppel MC; Jreissati M; Andrac L; Horschowski N; Sayag J
    Eur J Dermatol; 1998; 8(7):506-10. PubMed ID: 9854165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy.
    Boix-Vilanova J; Corral-Magaña O; Martin-Santiago A; Escalas J
    Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):54-56. PubMed ID: 30007081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periorbital Involvement in Early Stage Mycosis Fungoides.
    Wieser I; Huean A; Bush AE; Dabaja BS; Duvic M
    Acta Derm Venereol; 2017 Aug; 97(8):976-978. PubMed ID: 28421231
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypopigmented patches on the skin.
    Juhas E; English JC
    JAMA; 2013 Jan; 309(4):392-3. PubMed ID: 23340641
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
    Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
    Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
    D'Acunto C; Gurioli C; Neri I
    J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folliculotropic mycosis fungoides: challenging clinical, histopathological and immunohistochemical diagnosis.
    Malveira MIB; Pascoal G; Gamonal SBL; Castañon MCMN
    An Bras Dermatol; 2017; 92(5 Suppl 1):73-75. PubMed ID: 29267452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mycosis fungoides. Clinical characteristics and treatment of 6 patients].
    Dotterud LK; Aarstein K; Falk ES
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1850-2. PubMed ID: 1853318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of CD8
    Nojima K; Namiki T; Miura K; Tanaka M; Yokozeki H
    Australas J Dermatol; 2018 Aug; 59(3):e236-e238. PubMed ID: 29520788
    [No Abstract]   [Full Text] [Related]  

  • 17. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
    Huang J; Cowper S; Moss J; Girardi M
    J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ CD56+ mycosis fungoides with an indolent clinical behaviour: case report and literature review.
    Sawada Y; Sugita K; Kabashima R; Hino R; Nakamura M; Koga C; Tokura Y
    Acta Derm Venereol; 2010 Sep; 90(5):525-6. PubMed ID: 20814634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Annular erythema in a 78-year old woman].
    Booken N; Utikal J; Hildenbrand R; Goerdt S; Klemke CD
    J Dtsch Dermatol Ges; 2008 Apr; 6(4):321-3. PubMed ID: 18377564
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycosis fungoides: classic disease and variant presentations.
    Howard MS; Smoller BR
    Semin Cutan Med Surg; 2000 Jun; 19(2):91-9. PubMed ID: 10892710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.